Ozempic Ads Influence Woman's Health Journey
Irvine News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Tamar Abrams, a 69-year-old woman, turned to Ozempic after seeing its TV ads, despite not having diabetes. Novo Nordisk spent nearly $200 million on direct-to-consumer ads in 2022, exploiting a loophole in FDA rules. Experts debate the impact of these ads, with some arguing they raise awareness and drive doctor visits, while others claim they promote overuse of expensive new drugs. Abrams, now 90 pounds lighter, credits her success to the drug.
Support the show
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected]
View sources & latest updates
https://sources.thednn.ai/df062298a07cf09b